SAN FRANCISCO, Sept. 27, 2016 /PRNewswire/ -- Salesforce
(NYSE:CRM), the Customer Success Platform and world's #1 CRM
company, today announced that Eli Lilly and Company (NYSE: LLY) --
a Fortune 500 company and global leader in healthcare
-- has expanded its use of the Salesforce Platform to develop more
innovative and intuitive apps that are designed to personalize
patient support programs, unite care teams and ultimately improve
patient outcomes.
Since 1876, Lilly has succeeded in helping people live longer,
healthier and more active lives by creating high-quality medicines
that meet real patient needs. However, expectations have changed
tremendously in recent years, as many patients today want their
providers and pharmaceutical companies to connect with them through
mobile, social and cloud technologies.
To address evolving patient needs, Lilly turned to Salesforce to
help launch more than 50 apps over the last two years. These are
internal and external facing apps that Lilly has used to better
understand patient insights and engage in a way patients prefer.
For example, Lilly TrialGuide helps patients learn about
clinical trials, find one that's right for them and connect with
the clinic. With its expanded use of the Salesforce Platform, Lilly
is doubling down on its efforts to develop apps that will lead to
more relevant and meaningful touch-points along every step of the
patient journey.
Comments on the News
"Patient expectations have
changed dramatically in the last five years, and developing
innovative medicines is no longer enough," said Rob Brown, senior vice president and chief
marketing officer at Lilly. "Today, patients want relevant and
easily digestible information they can access when they need it
most that will help them better understand and manage their
condition. An app can be a great vehicle to help achieve this. With
Salesforce, we're planning for the future, developing technologies
and apps that enable us to meet patients at a point of need, rather
than at a point of request or requirement -- on any device or
channel."
"For the first time in history, healthcare IT is shifting toward
the patient, and companies that build strong communities and
connections around the medicines they provide will be able to
better listen to patient needs and ultimately provide better
outcomes," said Joshua Newman, M.D.,
chief medical officer, GM, Salesforce Healthcare and Life Sciences.
"With Salesforce, Lilly is making an industry leading investment,
building new apps to provide proactive support and engage patients
in familiar and effective ways. By guiding patients along their
treatment journeys, Lilly is truly putting them at the center of
their care."
Experience Lilly at Dreamforce 2016
See first-hand
how Lilly is getting smarter about patients to deliver better care
with a virtual patient journey at Dreamforce 2016, October 4-7 in San
Francisco. The full Lilly experience will be featured at the
Salesforce Campground in Moscone South, Halls A, B and C.
About Eli Lilly and Company
Lilly is a global
healthcare leader that unites caring with discovery to make life
better for people around the world. We were founded more than a
century ago by a man committed to creating high-quality medicines
that meet real needs, and today we remain true to that mission in
all our work. Across the globe, Lilly employees work to discover
and bring life-changing medicines to those who need them, improve
the understanding and management of disease, and give back to
communities through philanthropy and volunteerism. To learn more
about Lilly, please visit us at www.lilly.com and
http://newsroom.lilly.com/social-channels.
About Salesforce
Salesforce, the Customer Success
Platform and world's #1 CRM, empowers companies to connect with
their customers in a whole new way. For more information about
Salesforce (NYSE: CRM), visit: www.salesforce.com.
Any unreleased services or features referenced in this or other
press releases or public statements are not currently available and
may not be delivered on time or at all. Customers who purchase
Salesforce applications should make their purchase decisions based
upon features that are currently available. Salesforce has
headquarters in San Francisco,
with offices in Europe and
Asia, and trades on the New York
Stock Exchange under the ticker symbol "CRM." For more information
please visit http://www.salesforce.com, or call
1-800-NO-SOFTWARE.
This press release contains "forward-looking statements." All
statements other than historical facts included in this press
release, including, but not limited to, statements regarding the
timing and the closing of the transaction, the financing for the
transaction, the expected benefits of the transaction, prospective
performance and future business plans, and any assumptions
underlying any of the foregoing, are forward-looking statements.
These statements are based on current expectations of future
events. If underlying assumptions prove inaccurate or unknown, or
unknown risks or uncertainties materialize, actual results could
vary materially from the parties' expectations and projections.
These forward-looking statements reflect Salesforce's expectations
as of the date of this press release. Salesforce undertakes no
obligation to update the information provided herein.
Photo -
http://photos.prnewswire.com/prnh/20130612/SF30598LOGO
To view the original version on PR Newswire,
visit:http://www.prnewswire.com/news-releases/lilly-expands-use-of-salesforce-platform-to-build-more-apps-and-put-patients-at-the-center-of-their-care-300334562.html
SOURCE Salesforce